Research and Development grant cheat sheet
For companies looking to develop disruptive new technologies and gain a competitive edge, partnering with world-leading university researchers makes surprisingly good business sense.
A whole range of funding opportunities and tax incentives are offered by government, the University of Sydney and other bodies specifically to support firms partnering with university researchers.
Learn more about key medicine and health research and development opportunities available to your company:
Commercialisation, translation, and industry linked grants
Description |
|
There are a range of funding sources via the industry growth centres. One is MTPConnect and others are listed here. |
|
| AndHealth+ | A commercialisation acceleration program, where participants work with ANDHealth and an industry team of experts to drive growth in their business, with two stages of project funding made available through the ANDHealth Digital Health Accelerator Fund.
|
Engages Australia's best researchers in issues facing the new industrial economies and training the future workforce. The scheme supports collaborative research activity, between the Australian higher education sector and industry, designed to focus on strategic outcomes that are not independently realisable. Provides funding to Eligible Organisations to engage in cutting-edge research on new technologies and economic, commercial and social transformation which support the development of research outcomes that benefit industry partners in the Industrial Transformation Priorities. |
|
Fosters close partnerships between university-based researchers and other research end-users to provide innovative Higher Degree by Research (HDR) and postdoctoral training, for end-user focused research industries that are vital to Australia's future. Objectives:
|
|
|
|
Support the development of long-term strategic research alliances between higher education organisations and industry and other research end-users, in order to:
Must include at least one partner organisation. |
The SRI scheme provides funding to:
Funding may also be used to develop networks and initiate collaborations that would be unlikely to occur otherwise and, where appropriate, disseminate the outcomes of the collaborative activities funded under the scheme. |
|
ARII Round 4 of Grants will go organisations aiming to improve aged care via service delivery, technology and quality of care. Over the course of 2022-2024, the ARIIA Grant Program will consist of up to six rounds. ARIIA will fund projects with a maximum of $160,000 (ex GST) each along with mandatory co-contributions to support translational research projects running for a 12-month period. ARIIA is committed to awarding 60% of these grants to projects that have been developed through the Innovator Training Program and/or Aged Care Partnering Program. |
|
Funds innovative and collaborative health technologies. It drives discoveries that address key health challenges towards proof-of-concept and commercialisation, maximising entrepreneurship and idea potential. There is no specific disease focus area, however applicant will be expected to demonstrate how, through the usage of their device, the health and wellbeing of Australians will be improved with the potential to reduce the disease burden The medical device to be developed will be a physical device that is a smart monitoring device, diagnostic, personalised implant or a bionics device with a minimum classification of Class IIa as per TGA guidelines. |
|
CUREator was established by Brandon BioCatalyst in 2021 as a new approach for bridging the gap between where research grant funding ends and commercial investment begins. CUREator has received $90M in funding from the Australian Government’s Medical Research Future Fund and $6M from CSIRO, Australia’s national science agency. CUREator is a national biotechnology incubator run by Brandon BioCatalyst to support and accelerate the development of Australian biomedical research and innovations. CUREator provides grant funding programs targeting biomedical opportunities spanning from discovery to clinical development. |
|
Provides critical financial support for research projects with commercial potential |
|
Researchers submit innovative ideas related to therapeutic targets and technologies for drug discovery to gain funding to support their research financially to confirm their concepts. |
|
| Offer co-funding for industry-led research. A CRC must include at least 1 Australian business, and 1 research organisation, to be eligible for funding. | |
Projects must:
|
|
| Clinical Translation & Commercialisation - MedTech Program (CTCM) | MTPConnect’s CTCM program with industry partners identifies innovative medical devices that will support early clinical innovations and generate commercial returns. The $19.75M funding will nurture high-quality, home-grown medical device projects with strong commercial potential. The program offers financial assistance, educational support and infrastructure access to Australian SMEs supporting early clinical development, in partnership with Medical Technology Association of Australia (MTAA), Medical Device Partnering Program (MDPP), Cicada Innovations, the BridgeTech Program and Therapeutic Innovation Australia (TIA). |
Defence Advanced Research Projects Agency (DARPA) opportunities |
Established in 1958 as part of the U.S. Department of Defence, DARPA pursues opportunities for transformational change rather than incremental advances. It does so collaboratively as part of a robust innovation ecosystem that includes academic, corporate, and governmental partners. To fulfill its mission, the Agency relies on diverse performers from throughout this ecosystem to apply multi-disciplinary approaches to both advance knowledge through basic research and create innovative technologies that address current and predicted practical problems through applied research. |
Dementia Grants Program - Research Translation Grants (Also known as Dr Stuart and Bonnie Bartle Research Translation Grant) |
The Dr Stuart and Bonnie Bartle Research Translation Grant in Dementia Care aims to accelerate the real-world adoption of strategies that contribute to best practice approaches to dementia care. The scheme aims to attract proposals from new and established groups, which may be multi-disciplinary and include members with expertise in knowledge translation or implementation science. |
Funding opportunity from National Institute of Health (NIH) to solicit applications for the development of software to improve the acquisition, management, analysis, visualisation, and dissemination of data and knowledge for data science research on infectious and immune-mediated diseases (IID). Relevant IID data science research comprises, but is not limited to, computational methods to better understand disease mechanism, risk prediction, epidemiology, detection and diagnosis, treatment, and vaccines, aligned with the research mission of National Institute of Allergy and Infectious Diseases (NIAID). |
|
DHCRC working with healthcare providers and industry to identify problems and connect them with expertise to solve them. They take submissions for emerging digital health solutions through the idea submission process. |
|
Dravet Syndrome Foundation’s Research Grant Programs offers funding for research directly related to Dravet syndrome and associated disorders. These grants fund initial research hypotheses that have not been fully explored. The results extracted from this type of research will help bring untested research to the point that it can qualify for larger governmental funding. Research applications are judged principally on novelty of the hypotheses, innovative approaches with a direct relevance and application to Dravet syndrome and related epilepsies, scientific quality, strength of approach, and likelihood of success. |
|
The Genesis program supports founders with mentoring, a supportive entrepreneurial community and a chance to win $25,000 in the biannual startup program. |
|
| International Clinical Trial Collaborations (ICTC) Grant Opportunity (MRFF) | Aims to ensure the next generation of talented Australians have the capacity to make and progress great medical discoveries and promotes opportunities for active clinical researchers to work in partnership with professional colleges and industry. |
Advanced International Collaborative Research Program - Adopting Sustainable Partnerships for an Innovative Research. The Japan Science and Technology Agency (JST) will support international collaborative research between Japanese and foreign researchers based in several leading research countries to support the following aims to:
|
|
A competitive technology program that encourages and supports investment in the development and commercialisation of medical devices and related technologies in NSW. Provides support to individuals, companies, public and private hospitals, medical research institutes, universities and the medical devices industry to take local innovation to market. |
|
The MRCF is the largest life science investment fund in Australia and New Zealand. They are a unique collaboration between major Australian superannuation funds, the Australian and New Zealand governments, Australian state governments and over 50 leading medical research institutes and research hospitals. |
|
This program provides organisations with funding of up to $2 million over two years from 2023-24 to improve the understanding of infections in hospitals that drive antimicrobial resistance and develop interventions to reduce infections. MRFF 2023 closes on 20 September 2023. |
|
Funds the most suitable organisation who can identify and select a number of Australian small and medium enterprises (SMEs) undertaking early-stage medical research and medical innovation projects that have commercial potential. The successful organisation, in partnership with SMEs, aims to progress and support medical research and medical innovation projects. |
|
The Medical Research Future Fund (MRFF) Clinical Trials Activity Initiative aims to
It offers up to $12,600,000.00 total amount and closes on 7 February 2024. |
|
Multiple Sclerosis Research Australia (MSRA) Incubator research grant |
THE MSRA Incubator grants provide seed funding for the early stages of innovative new research efforts, with the aim of generating preliminary data needed to support future grant applications. |
Improve health outcomes and promote or improve translation of research outcomes into policy and/or practice. The CRE scheme will also support researchers in capacity building activities, including in specific areas of need identified by NHMRC. |
|
Supports high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health. Teams of up to 10 Chief Investigators may seek funding for up to five years. Laboratory-based research or mechanistic studies that are not clinical trials or cohort studies should be directed to other grant opportunities, such as the NHMRC’s Ideas Grant Scheme. |
|
Proof-of-concept stage projects that specifically drive towards a commercial outcome within a foreseeable timeframe. |
|
Provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions, undertake research, interpret the findings and implement the findings into policy and practice. Partnership Projects create partnerships among decision makers, policy makers, managers, clinicians and researchers. |
|
| Pipeline Accelerator TIA (Therapeutics Innovation Australia) | Supports and facilitates researcher and SME access to a diverse range of Australian translational medical research capabilities. One specific mechanism, providing rapid, entry level access is via a voucher-style scheme - the Pipeline Accelerator. |
| The Brain and Mind Centre Partnership Program | Promotes research partnerships between researchers and industry, community and health organisations with the aim of establishing meaningful, long-lasting strategic collaborations with industry and other research end-users. This program provides up to $50,000 in funding to successful applicants, with some matched funding from a partner, for work in neuroscience and mental health across child, youth and ageing domains. Expressions of interest close on 30 September 2024. |
Provide between $200,000-$750,000 to help eligible organisations develop innovative preventative, diagnostic, therapeutic and/or disease management products/solutions for identified priorities associated with diabetes and cardiovascular disease. |
|
Refer to the Office for Global Health |
Training, mentoring and development programs linked to commercialisation
Description |
|
Domestic and international student placements - connects PhD students with industry through short-term internships. These opportunities empower students to thrive in a practical research environment and for businesses to innovate and be future-ready. Our program also links businesses to fresh ideas and provides pathways for universities to expand research collaborations with industry. Not for profit program. Specifically, women and underrepresented STEM, indigenous and disadvantaged students. |
|
Activate with River City Labs, a program designed to get your idea off the ground. For early-stage startups looking to get direct access to coaches Mentors and Entrepreneurs who will coach your startup to activate! Weekly mentoring sessions, invites to networking events and opportunity to pitch to VCs. |
|
Multidisciplinary teams are assembled after a competitive application process. Each team consists of five people, from a healthcare, science, engineering, business and a wildcard discipline. Team members are from all career levels but are not specialists within the area of immersion. Each team is placed, for a brief period, within a hospital department (e.g., an emergency department, surgical department etc). During this period, the teams undertake needs analysis, observing and questioning processes that are considered common practice. Through this process, teams identify potential solutions (i.e., a new medical device, software solution or process) and narrow this down to an ideas shortlist. |
|
A $22.3 million Medical Research Future Fund initiative, that provides up to $1 million in matched funding to nurture the translation of new therapies, technologies and medical devices through to the proof-of-concept stage, including:
|
|
Equips researchers and entrepreneurs with the knowledge, skills and networks to enable the successful commercialisation of new pharmaceuticals. Delivered by Queensland University of Technology, the Bridge Program is funded by MTPConnect and a consortium of 10 pharmaceutical companies and universities. |
|
A national professional development program that trains researchers and entrepreneurs on how to effectively navigate the commercialisation pathway of new medical technologies. Learn skills on medical devices. |
|
Supports the medical and health sector by investing in their people to build capacity, form stronger networks across the state and nurture innovative medical technologies. Fast-tracks innovative ideas that will revolutionise the healthcare sector, improve patient outcomes, and provide economic opportunities for emerging MedTech and Biotech businesses in NSW. This end-to-end Program consists of three verticals which are broken down into seminars and courses. This Program is available to NSW innovators for the next four years and best of all, it is free. |
|
The ON program is delivered as part of a broad suite of innovation initiatives. The directive of our innovation program remains the same as when the ON program was first formed to fast-track technology and ideas into the market and to get it into people's hands more quickly. Originally developed as part of CSIRO's Innovation Catalyst in 2015, the ON program has delivered industry-leading innovation training and support to thousands of people from Australian universities and research institutes. Our program of events and experiences delivered throughout this time (including ON Accelerate and ON Prime) has been successful in driving impact and creating cultural change. |
|
Winners of the three-minute pitch at the Falling Walls Lab can participate in the international Falling Walls Science Summit extended programs, coaching, networking, workshopping and career development areas. Finalists compete for the Emerging Talents category. |
|
One of the first decisions a business owner makes is the structure of the company. There are several different types of business entities, one of which is an LLC, which is an abbreviation for limited liability company. But what is an LLC? How does it operate? How is it registered with the state? This guide provides an excellent introduction to this kind of business entity and answers frequently asked questions. |
|
ProtoX is a free part-time mentoring program created to support individuals and teams from within the University of Sydney community who are committed to building a startup or delivering impactful research. Delivered by INCUBATE, the award-winning startup program, ProtoX is backed by industry learning and facilitated by mentors with depth of experience in startups and research commercialisation. ProtoX has two unique specialised programs:
|
|
The Accelerator is a 15-month accelerator for prototype stage MedTech, HealthTech and BioTech startups. Industry-led, venture backed program will accelerate your technology development, build your team capability and provide a pathway to access up to $3m+ pre-seed to series A investment. Connect you to global startup pathways, leading you into clinical trials, advanced manufacturing and at-scale technology deployment. Milestone momentum in the program will be rewarded with capital injection points. |
|
As with all businesses, the funding of startups is an important and complex task. The startup culture has developed its own nuanced funding patterns in the past couple of decades.It can be tricky to navigate if you’re not familiar with the lingo and the important players at each stage. This easy-to-follow guide could be the quickest way to navigate through each stage of the complex startup funding task. |
|
SPARK is a translational research and education program that provides training, mentorship, and milestone funding to research teams working in early-stage drug development. |
|
The Johnson & Johnson (J&J) Scholars Award Program aims to fuel development of female STEM2D leaders and feed the STEM2D talent pipeline by awarding and sponsoring women at critical points in their careers. J&J is looking to identify global women leading in both their research fields and leading as mentors, to be a vision for girls and other women in STEM2D. |